Efficacy and safety of ipragliflozin as an add-on to a sulfonylurea in Japanese patients with inadequately controlled type 2 diabetes: results of the randomized, placebo-controlled, double-blind, phase III EMIT study
Crossref DOI link: https://doi.org/10.1007/s13340-014-0184-9
Published Online: 2014-07-18
Published Print: 2015-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kashiwagi, Atsunori
Akiyama, Noriko
Shiga, Takanori
Kazuta, Kenichi
Utsuno, Atsushi
Yoshida, Satoshi
Ueyama, Eiji
Text and Data Mining valid from 2014-07-18